Search
In the first half of 2025, the once-booming initial public offering landscape underwent a significant slowdown. IPO volume and proceeds have tumbled to levels unseen since the early days of the pandemic, marking a stark departure from the exuberance of 2021.
As issuers and investors navigate this new terrain, a thorough recalibration of valuation expectations is underway. This shift reflects not only evolving macroeconomic forces but also a maturing perspective on risk, performance metrics, and long-term value creation.
Before the pandemic, IPO markets were already reaching historic highs, driven by technology companies and special purpose acquisition companies (SPACs). However, regulatory scrutiny and shifting investor priorities quickly dampened that fervor.
The peak of the IPO market in 2021 saw an unprecedented 397 listings in the U.S. and over $140 billion in proceeds during the first half of that year. Buoyed by low interest rates, pent-up demand, and aggressive private funding rounds, many companies rushed to tap public markets.
In 2022, markets cooled amid inflationary pressures and rising rates. A modest rebound occurred in 2023 with 109 listings, but by mid-2024 the pace plateaued at 150 deals. Now in 2025, the count of 84 IPOs through mid-June highlights how quickly sentiment has shifted.
A detailed look at the numbers underscores the breadth of the slowdown. In the first five months of 2025, 25 traditional offerings raised just over $11 billion, compared to 28 IPOs raising $12.7 billion during the same period in 2024.
Average deal size has also contracted. Where six-figure valuations were common in growth sectors, median floats now hover closer to $300 million, reflecting a more cautious approach to pricing.
In India, overall fundraising across listing platforms was down 18% year-to-date, while EMEA saw a 20% reduction in new equity issues compared to mid-2024 levels. These figures illustrate a synchronized global recalibration.
Multiple overlapping factors have driven the current pause in IPO activity. The lingering effects of inflation have kept many issuers tentative, as consumer price pressures and input costs remain uncertain.
Geopolitical tensions, trade policy shifts, and the potential for further interest-rate changes have compounded investor wariness. The prospect of rate cuts teases a boost to equities, but memories of turbulent cut cycles temper enthusiasm.
Meanwhile, heightened ESG scrutiny and evolving regulatory standards have added complexity, especially for high-profile technology and energy listings. Firms now face a more rigorous due diligence process.
After the exuberance of 2021, the public markets are no longer willing to endorse aggressive multiples for growth companies without solid financials. This has precipitated a broader valuation reset.
Investors are focused on companies that demonstrate clear paths to profitability and positive cash flow. Firms lacking near-term revenue visibility or robust balance sheets face steep discounts or postponements.
Average post-IPO returns for deals above $100 million hovered around -1% in early 2025. As a result, issuers are embracing wider discounts and less aggressive pricing as the new norm in order to secure investor backing.
One biotech CFO noted that after losing momentum during late-stage rounds, they had to lower their pricing range by 15% to attract cornerstone investors, reflecting a more disciplined market dynamic.
Not all industries are feeling the chill. Healthcare and life sciences have remained relatively active, driven by strong research pipelines, regulatory catalysts, and investor appetite for stable fundamentals.
Technology and pre-profit startups, which flourished with lofty private valuations, now encounter more scrutiny. Some are turning to private investment in public equity deals and secondary transactions as viable alternatives to traditional IPO routes.
Regional variations also matter: Asian exchanges like Hong Kong and Singapore have adjusted listing rules to attract quality issuers, while U.S. markets maintain strict listing criteria.
This slowdown is not an isolated U.S. phenomenon. India’s IPO segment, which climbed to world number two in 2024, has seen mainboard listings drop from 26 in Q2 FY25 to only nine in Q4 of the same fiscal year.
European issuers have similarly postponed deals until policy clarity emerges on Brexit-inspired regulations and digital services taxes. Chinese companies are weighing U.S. regulatory risks versus listings in their domestic markets.
Overall, the global slowdown highlights how companies and investors are aligning around a more uniform set of expectations for value and risk management.
Industry analysts believe that the current correction may lay the groundwork for a healthier IPO environment. By tempering valuation excesses, the market can refocus on underlying business value and sustainable growth.
Once the macroeconomic outlook stabilizes—through clearer Fed guidance or easing geopolitical tensions—deal flow could experience a meaningful rebound. This recalibration may close the gap between private and public market valuations.
As one veteran underwriter remarked, moments of pause create space to reset, enabling investors to identify the next generation of public market winners with confidence.
For issuers contemplating their timing, industry experts advise gauging investor demand by engaging with cornerstone investors well in advance, as roadshow receptivity now serves as an early signal of market appetite.
The IPO market’s slowdown in 2025 reflects a natural evolution after the heady days of 2021. While the dip in volumes and proceeds might appear concerning, it also signals a shift toward more disciplined valuation practices.
Companies with solid business models, transparent financials, and credible paths to profitability will continue to attract interest. In this environment, issuers and investors alike must align their expectations with market realities.
Ultimately, this phase of recalibration and caution could pave the way for a stronger, more sustainable IPO cycle—one where valuations are grounded in performance and deal structures benefit all stakeholders.
Looking ahead, the next wave of public market entrants will likely emerge from sectors with proven cash flows and resilient business models, setting the stage for a measured resurgence in IPO activity by late 2025.
References
